USFDA accepts regulatory submission for Pfizer alopecia areata treatment Ritlecitinib Ruchika Sharma10 Sept 2022 5:15 PM ISTAlopecia areata is an autoimmune disease that has an underlying immuno-inflammatory pathogenesis and develops when the immune system attacks the...
Alopecia areata patients are at risk for developing cardiovascular conditions, study says Medha Baranwal20 Jun 2022 7:30 PM ISTPoland: Patients with alopecia areata (AA) at risk of endothelial dysfunction, according to results of a case-control study. The study found that AA...
FDA approves Olumiant as first systemic therapy for treatment of alopecia areata Dr. Kamal Kant Kohli15 Jun 2022 9:00 AM ISTThe U.S. Food and Drug Administration has approved Olumiant as first systemic therapy for the treatment of alopecia areata.Olumiant...
FIRST: Eli Lilly gets USFDA nod for alopecia areata pill Olumiant Ruchika Sharma14 Jun 2022 1:00 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly and is available through specialty pharmacies nationwide.
Investigational JAK inhibitor found safe, effective in moderate to severe alopecia areata in phase 3 study Dr. Kamal Kant Kohli26 May 2022 8:00 PM ISTAlopecia areata is an autoimmune disorder that results in patchy or complete scalp hair loss. CTP-543 is an investigational oral selective inhibitor...
Patients with Psoriasis at greater risk of Developing Alopecia Areata Dr. Shravani Dali9 May 2022 9:00 AM ISTPatients with Psoriasis are at a greater risk of Developing Alopecia Areata, according to a recent study published in The Journal of Dermatology. ...
Cases of pediatric alopecia areata double in last decade, finds JAMA study Medical Dialogues Editorial Team11 April 2022 9:15 AM ISTUSA: A new study published in the Journal of the American Medical Association - Dermatology looked at the prevalence and incidence rates of pediatric...
Trials BRAVE AA1 and BRAVE AA2 report Baricitinib to treat Alopecia Areata Dr. Nandita Mohan4 April 2022 5:00 PM ISTAlopecia areatai.e hair loss is a known autoimmune condition affecting the scalp, eyebrows, and eyelashes, for which treatments are limited....
Baricitinib effects hair regrowth in severe Alopecia Areata: NEJM MD Editorial Team29 March 2022 11:00 AM ISTAlopecia areata is a known autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are...
Study: Not all Alopecia Areata Patients Might Suffer Vitamin D Deficiency MD Bureau16 Feb 2022 9:45 AM ISTAlopecia areata (AA) has been postulated to be an autoimmune disease affecting the hair follicles. Environmental costimulatory factors, such as...
Oral tofacitinib helps in alopecia areata in children Dr. Nandita Mohan25 Dec 2021 4:05 PM ISTA recent study in the journal Pediatric Dermatology showed oral tofacitinib to be clinically effective and well-tolerated in the majority of pediatric...
Medical Bulletin 24/December/2021 Dr. Nandita Mohan24 Dec 2021 4:00 PM ISTHere are Top Medical stories of the dayStatins reduces risk of ischemic, hemorrhagic strokeA significant association exists between statin adherence...
